Related Experiment Video
Updated: Feb 25, 2026

Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging
Published on: May 24, 2021
The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure
Mark A Peterzan1,2, Oliver J Rider2, Lisa J Anderson1
1Cardiology Clinical Academic GroupSt George's Hospital, London, UK.
Insights
Cardiovascular magnetic resonance imaging is crucial for diagnosing heart failure and identifying its causes. This imaging technique offers accurate, radiation-free assessments of heart function and tissue, aiding in treatment decisions.
Area of Science:
- Cardiology
- Medical Imaging
- Cardiovascular Diseases
Background:
- Cardiovascular imaging is essential for managing heart failure patients.
- Cardiovascular magnetic resonance imaging (CMR) is established for assessing heart failure syndromes and identifying etiology.
- The roles of CMR in prognosis and guiding therapy are expanding.
Purpose of the Study:
- To highlight the established and emerging roles of cardiovascular magnetic resonance imaging in heart failure assessment.
- To detail the key strengths of CMR in evaluating cardiac function and tissue characteristics.
- To discuss the specific applications of CMR in conditions like iron overload cardiomyopathy, cardiac amyloidosis, and Anderson-Fabry disease.
Main Methods:
- Utilizes cardiovascular magnetic resonance imaging (CMR).
- Employs techniques such as T2* for iron overload assessment and T1 for specific disease therapies.
- Assesses left and right ventricular volumes, myocardial tissue, thrombus, and scar.
Main Results:
- CMR provides accurate and reproducible assessments of cardiac structure and function.
- It offers a radiation-free imaging modality with an unrestricted field of view.
- CMR excels in characterizing myocardial tissue, thrombus, and scar, and in assessing ventricular volumes.
Conclusions:
- Cardiovascular magnetic resonance imaging is a vital tool in the comprehensive assessment of heart failure.
- Its established role in etiology identification and emerging applications in prognosis and therapy guidance underscore its importance.
- Specific CMR sequences like T2* and T1 are crucial for managing conditions such as iron overload cardiomyopathy and specific genetic heart diseases.
Abstract:
Cardiovascular imaging is key for the assessment of patients with heart failure. Today, cardiovascular magnetic resonance imaging plays an established role in the assessment of patients with suspected and confirmed heart failure syndromes, in particular identifying aetiology. Its role in informing prognosis and guiding decisions around therapy are evolving. Key strengths include its accuracy; reproducibility; unrestricted field of view; lack of radiation; multiple abilities to characterise myocardial tissue, thrombus and scar; as well as unparalleled assessment of left and right ventricular volumes. T2* has an established role in the assessment and follow-up of iron overload cardiomyopathy and a role for T1 in specific therapies for cardiac amyloid and Anderson-Fabry disease is emerging.
More Related Videos
12:24Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
06:29Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
Related Concept Videos
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Magnetic Resonance Imaging
Pathophysiology of Heart Failure
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure IV: Classification and Diagnostic Evaluation